JelliSee Ophthalmics
JelliSee Ophthalmics is a startup headquartered in Mclean, United States, founded in 2019. It has raised at least $3.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
JelliSee Ophthalmics has raised at least $3.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
JelliSee Ophthalmics sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Mclean
- Adelphi Data
- Apira Technologies
- canopie
- Permiso Security
- Retension Pharmaceuticals
- Rilian Technologies
- ScreenSteps
- v.law
- Zephyr AI
Related
Questions and answers
What does JelliSee Ophthalmics do?
JelliSee Ophthalmics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has JelliSee Ophthalmics raised?
At least $3.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is JelliSee Ophthalmics based?
JelliSee Ophthalmics is headquartered in Mclean, United States.
When was JelliSee Ophthalmics founded?
JelliSee Ophthalmics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.